28+ Moderna Covid Vaccine Phase 3 Results Background. Moderna says that it will be submitting for an emergency use authorization of its vaccine candidate based on the results within the coming weeks moderna inc. Phase 3 moderna develops vaccines based on messenger rna (mrna) to produce viral proteins in on sept.
Moderna (nasdaq:mrna) will determine whether to submit a dossier to fda requesting emergency use authorization based on an assessment of whether the potential benefit of the vaccine outweighs the. Moderna currently has 9 development candidates in its prophylactic vaccines modality. The company said secondary endpoints include but early results for all the candidates have generally been positive.
Moderna is set to begin its phase 3 clinical trial on a coronavirus vaccine.
Moderna currently has 9 development candidates in its prophylactic vaccines modality. That trial, which involved 45 participants, was meant to test a new drug's safety, not its effectiveness. But the company said results from all 45 participants showed they developed antibodies key to fighting the. Moderna is set to begin its phase 3 clinical trial on a coronavirus vaccine.